
Therapeutic Respiratory Devices Market Report 2023-2033
Description
Therapeutic Respiratory Devices Market Report 2023-2033
The Therapeutic Respiratory Devices Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Rising Prevalence of Respiratory Diseases Driving Market Growth
The number of respiratory disorders is growing globally due to a variety of causes such as pollution, lifestyle choices, and smoking. According to WHO, an estimated 65 million individuals have moderate to severe chronic obstructive pulmonary disease (COPD), with around 3 million dying each year, making it the world's third greatest cause of death and the number is growing. About 334 million people worldwide are suffering from asthma, childhood's most frequent chronic condition, impacting 14% of children. The frequency of asthma in children is rising.
The primary factors driving the growth of the therapeutic respiratory devices market are an increase in the frequency and incidence of respiratory disorders, technical innovation, and increasing government and non-governmental organisation support for respiratory disease healthcare awareness. Increasing awareness of respiratory disorders among the general population and governments is predicted to improve the market for respiratory medicine delivery products.
Limited Reimbursements Likely to Hamper Market Growth
Patients' reimbursements are frequently used to pay for medical services. There is now a reimbursement gap in the diagnostic sector as a whole, and in respiratory therapy diagnostics in particular. The reimbursement schemes for PAP equipment and oral appliances differ across Europe and are only applicable in a few countries (devices not covered by insurance represent a small share of the market in the region). Moreover, respiratory care equipment is not fully covered by insurance in the majority of Asian and RoW nations. Over the projected period, high cost of therapeutic respiratory devices is likely to further constrain the market.
What Questions Should You Ask before Buying a Market Research Report?
Forecasts to 2033 and other analyses reveal commercial prospects
Segments Covered in the Report
Product
- Dry Powder Inhalers
- Soft Mist Inhalers
- Neonatal Ventilators
- Passover Humidifiers
- Integrated Humidifiers
- Built-in Humidifiers
- Stand-alone Humidifiers
- Auto-titrating Positive Airway Pressure Devices
- Bi-level Positive Airway Pressure Devices
- Portable Oxygen Concentrators
- Piston-based Hand-held Nebulizers
- Ultrasonic Nebulizers
Application
North America
Leading companies and the potential for market growth
3M Health Care
Airsep Corporation (Chart Industries)
AptarGroup, Inc.
AstraZeneca
Becton, Dickinson and Company (BD)
Boehringer Ingelheim International GmbH
Cipla Inc.
Fisher & Paykel Healthcare Limited
GE Healthcare
GF Health Products, Inc.
GSK plc
Hamilton Medical
Invacare
Koninklijke Philips N.V.
Medisana GmbH
Medtronic
Merck & Co., Inc.
Novartis AG
OMRON Corporation
Recipharm AB
ResMed
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Smiths Medical, Inc.
Sunovion Pharmaceuticals Inc.
Teva Pharmaceutical Industries Ltd.
Overall world revenue for Therapeutic Respiratory Devices Market, 2023 to 2033 in terms of value the market will surpass US$63 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Therapeutic Respiratory Devices Market, 2023 to 2033 report help you?
In summary, our 450+ page report provides you with the following knowledge:
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Therapeutic Respiratory Devices Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher..
The publisher is using a password system to access single user and team licenses. Single user (non-printable) and team licenses expire after 12 month period. In the case of team license purchases, the publisher requires all email addresses for the licensed users prior to fulfilment.
The Therapeutic Respiratory Devices Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Rising Prevalence of Respiratory Diseases Driving Market Growth
The number of respiratory disorders is growing globally due to a variety of causes such as pollution, lifestyle choices, and smoking. According to WHO, an estimated 65 million individuals have moderate to severe chronic obstructive pulmonary disease (COPD), with around 3 million dying each year, making it the world's third greatest cause of death and the number is growing. About 334 million people worldwide are suffering from asthma, childhood's most frequent chronic condition, impacting 14% of children. The frequency of asthma in children is rising.
The primary factors driving the growth of the therapeutic respiratory devices market are an increase in the frequency and incidence of respiratory disorders, technical innovation, and increasing government and non-governmental organisation support for respiratory disease healthcare awareness. Increasing awareness of respiratory disorders among the general population and governments is predicted to improve the market for respiratory medicine delivery products.
Limited Reimbursements Likely to Hamper Market Growth
Patients' reimbursements are frequently used to pay for medical services. There is now a reimbursement gap in the diagnostic sector as a whole, and in respiratory therapy diagnostics in particular. The reimbursement schemes for PAP equipment and oral appliances differ across Europe and are only applicable in a few countries (devices not covered by insurance represent a small share of the market in the region). Moreover, respiratory care equipment is not fully covered by insurance in the majority of Asian and RoW nations. Over the projected period, high cost of therapeutic respiratory devices is likely to further constrain the market.
What Questions Should You Ask before Buying a Market Research Report?
- How is the therapeutic respiratory devices market evolving?
- What is driving and restraining the therapeutic respiratory devices market?
- How will each therapeutic respiratory devices submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
- How will the market shares for each therapeutic respiratory devices submarket develop from 2023 to 2033?
- What will be the main driver for the overall market from 2023 to 2033?
- Will leading therapeutic respiratory devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
- Who are the leading players and what are their prospects over the forecast period?
- What are the therapeutic respiratory devices projects for these leading companies?
- How will the industry evolve during the period between 2023 and 2033? What are the implications of therapeutic respiratory devices projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the therapeutic respiratory devices market?
- Where is the therapeutic respiratory devices market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
- Our 450-page report provides 183 tables and 300 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them – NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
Forecasts to 2033 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising therapeutic respiratory devices prices and recent developments.
Segments Covered in the Report
Product
- Inhalers
- Dry Powder Inhalers
- Soft Mist Inhalers
- Ventilators
- Neonatal Ventilators
- Humidifiers
- Passover Humidifiers
- Integrated Humidifiers
- Built-in Humidifiers
- Stand-alone Humidifiers
- Positive Airway Pressure Devices
- Auto-titrating Positive Airway Pressure Devices
- Bi-level Positive Airway Pressure Devices
- Oxygen concentrators
- Portable Oxygen Concentrators
- Nebulizers
- Piston-based Hand-held Nebulizers
- Ultrasonic Nebulizers
Application
- Asthma
- Chronic Obstructive Pulmonary Disease
- Cystic Fibrosis
- Acute Respiratory Failure
- Obstructive Sleep Apnea
- Respiratory Distress Syndrome
- Others
- Homecare Settings
- Hospitals
- Others
- Retail Pharmacies
- Hospitals Pharmacies
- Online Pharmacies
North America
- U.S.
- Canada
- Germany
- UK
- France
- Spain
- Italy
- Russia
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- GCC
- South Africa
- Rest of MEA
Leading companies and the potential for market growth
3M Health Care
Airsep Corporation (Chart Industries)
AptarGroup, Inc.
AstraZeneca
Becton, Dickinson and Company (BD)
Boehringer Ingelheim International GmbH
Cipla Inc.
Fisher & Paykel Healthcare Limited
GE Healthcare
GF Health Products, Inc.
GSK plc
Hamilton Medical
Invacare
Koninklijke Philips N.V.
Medisana GmbH
Medtronic
Merck & Co., Inc.
Novartis AG
OMRON Corporation
Recipharm AB
ResMed
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Smiths Medical, Inc.
Sunovion Pharmaceuticals Inc.
Teva Pharmaceutical Industries Ltd.
Overall world revenue for Therapeutic Respiratory Devices Market, 2023 to 2033 in terms of value the market will surpass US$63 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Therapeutic Respiratory Devices Market, 2023 to 2033 report help you?
In summary, our 450+ page report provides you with the following knowledge:
- Revenue forecasts to 2033 for Therapeutic Respiratory Devices Market, 2023 to 2033 Market, with forecasts for product, application, end-users, and distribution channel, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2033 for five regional and 18 key national markets – See forecasts for the Therapeutic Respiratory Devices Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market – including company profiles for 25 of the major companies involved in the Therapeutic Respiratory Devices Market, 2023 to 2033.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Therapeutic Respiratory Devices Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher..
The publisher is using a password system to access single user and team licenses. Single user (non-printable) and team licenses expire after 12 month period. In the case of team license purchases, the publisher requires all email addresses for the licensed users prior to fulfilment.
Table of Contents
450 Pages
- 1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Therapeutic Respiratory Devices Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report
- 1.6 Who is This Report for?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Reports
- 1.10 About
- 2 Executive Summary
- 3 Market Overview
- 3.1 Key Findings
- 3.2 Market Dynamics
- 3.2.1 Market Driving Factors
- 3.2.1.1 Rising Prevalence of Respiratory Disorders to Fuel Therapeutic Respiratory Devices Market Growth
- 3.2.1.2 Rising Geriatric Population to Boost Market Growth
- 3.2.1.3 Technological Advancements Leading to Adoption of Therapeutic Devices in Homecare Settings
- 3.2.1.4 Increasing Economic Burden of Asthma and Chronic Respiratory Diseases Anticipated to Spur Market Growth
- 3.2.2 Market Restraining Factors
- 3.2.2.1 Limited Reimbursements to Hamper Market Growth
- 3.2.2.2 Lack of Awareness to Restrain Market Growth
- 3.2.2.3 High Cost of Respiratory Medication Coupled with Under Diagnosis of Condition Likely to Restrain Market Growth
- 3.2.2.4 Respiratory Devices Manufacturing Complications is Hindering the Growth
- 3.2.3 Market Opportunities
- 3.2.3.1 Growing Demand for Home Care Therapeutic Devices
- 3.2.3.2 Increasing Initiatives by Market Player To Create Awareness about Respiratory Drugs and Treatments
- 3.2.3.3 Digital Platform for Respiratory Related Therapies to Offer Lucrative Growth Opportunities
- 3.2.3.4 Increased Demand from Emerging Markets
- 3.2.4 Market Challenges
- 3.2.4.1 Asthma Inhalers Are Among the Most Complex Medical Devices in Widespread Use
- 3.2.4.2 Poor Treatment Adherence
- 3.2.4.3 Low-Income Countries Face Extra Challenges
- 3.2.4.4 Disruption of Clinical Trials Due to Pandemic Breakout
- 3.3 COVID-19 Impact Analysis
- 3.4 Porter’s Five Forces Analysis
- 3.4.1 Supplier Power
- 3.4.2 Buyer Power
- 3.4.3 Competitive Rivalry
- 3.4.4 Threat from Substitutes
- 3.4.5 Threat of New Entrants
- 3.5 PEST Analysis
- 3.5.1 Political Factors Impacting Therapeutic Respiratory Devices Market
- 3.5.2 Economic Factors Impacting Therapeutic Respiratory Devices Market
- 3.5.3 Social Factors Impacting Therapeutic Respiratory Devices Market
- 3.5.4 Technological Factors Impacting Therapeutic Respiratory Devices Market
- 4 Therapeutic Respiratory Devices Market Analysis by Product
- 4.1 Key Findings
- 4.2 Product Segment: Market Attractiveness Index
- 4.3 Therapeutic Respiratory Devices Market Size Estimation and Forecast by Product
- 4.4 Inhalers
- 4.4.1 Inhalers Market Forecast by Region, 2023-2033 (US$ bn)
- 4.4.2 Inhalers Market Share by Region, 2023 & 2033 (%)
- 4.4.3 Metered Dose Inhalers
- 4.4.3.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.4.3.2 Market Share by Region, 2023 & 2033 (%)
- 4.4.4 Dry Powder Inhalers
- 4.4.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.4.4.2 Market Share by Region, 2023 & 2033 (%)
- 4.4.5 Soft Mist Inhalers
- 4.4.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.4.5.2 Market Share by Region, 2023 & 2033 (%)
- 4.5 Ventilators
- 4.5.1 Ventilators Market Forecast by Region, 2023-2033 (US$ bn)
- 4.5.2 Ventilators Market Share by Region, 2023 & 2033 (%)
- 4.5.3 Adult Ventilators
- 4.5.3.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.5.3.2 Market Share by Region, 2023 & 2033 (%)
- 4.5.4 Neonatal Ventilators
- 4.5.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.5.4.2 Market Share by Region, 2023 & 2033 (%)
- 4.6 Humidifiers
- 4.6.1 Humidifiers Market Forecast by Region, 2023-2033 (US$ bn)
- 4.6.2 Humidifiers Market Share by Region, 2023 & 2033 (%)
- 4.6.3 Heated Humidifiers
- 4.6.3.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.6.3.2 Market Share by Region, 2023 & 2033 (%)
- 4.6.4 Passover Humidifiers
- 4.6.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.6.4.2 Market Share by Region, 2023 & 2033 (%)
- 4.6.5 Integrated Humidifiers
- 4.6.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.6.5.2 Market Share by Region, 2023 & 2033 (%)
- 4.6.6 Built-in Humidifiers
- 4.6.6.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.6.6.2 Market Share by Region, 2023 & 2033 (%)
- 4.6.7 Stand-alone Humidifiers
- 4.6.7.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.6.7.2 Market Share by Region, 2023 & 2033 (%)
- 4.7 Positive Airway Pressure Devices
- 4.7.1 Positive Airway Pressure Devices Market Forecast by Region, 2023-2033 (US$ bn)
- 4.7.2 Positive Airway Pressure Devices Market Share by Region, 2023 & 2033 (%)
- 4.7.3 Continuous Positive Airway Pressure Devices
- 4.7.3.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.7.3.2 Market Share by Region, 2023 & 2033 (%)
- 4.7.4 Auto-titrating Positive Airway Pressure Devices
- 4.7.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.7.4.2 Market Share by Region, 2023 & 2033 (%)
- 4.7.5 Bi-level Positive Airway Pressure Devices
- 4.7.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.7.5.2 Market Share by Region, 2023 & 2033 (%)
- 4.8 Oxygen Concentrators
- 4.8.1 Oxygen Concentrators Market Forecast by Region, 2023-2033 (US$ bn)
- 4.8.2 Oxygen Concentrators Market Share by Region, 2023 & 2033 (%)
- 4.8.3 Fixed Oxygen Concentrators
- 4.8.3.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.8.3.2 Market Share by Region, 2023 & 2033 (%)
- 4.8.4 Portable Oxygen Concentrators
- 4.8.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.8.4.2 Market Share by Region, 2023 & 2033 (%)
- 4.9 Nebulizers
- 4.9.1 Nebulizers Market Forecast by Region, 2023-2033 (US$ bn)
- 4.9.2 Nebulizers Market Share by Region, 2023 & 2033 (%)
- 4.9.3 Compressor-based Nebulizers
- 4.9.3.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.9.3.2 Market Share by Region, 2023 & 2033 (%)
- 4.9.4 Piston-Based Hand-Held Nebulizers
- 4.9.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.9.4.2 Market Share by Region, 2023 & 2033 (%)
- 4.9.5 Ultrasonic Nebulizers
- 4.9.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 4.9.5.2 Market Share by Region, 2023 & 2033 (%)
- 5 Therapeutic Respiratory Devices Market Analysis by Application
- 5.1 Key Findings
- 5.2 Application Segment: Market Attractiveness Index
- 5.3 Therapeutic Respiratory Devices Market Size Estimation and Forecast by Application
- 5.4 Asthma
- 5.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 5.4.2 Market Share by Region, 2023 & 2033 (%)
- 5.5 Chronic Obstructive Pulmonary Disease
- 5.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 5.5.2 Market Share by Region, 2023 & 2033 (%)
- 5.6 Cystic Fibrosis
- 5.6.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 5.6.2 Market Share by Region, 2023 & 2033 (%)
- 5.7 Acute Respiratory Failure
- 5.7.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 5.7.2 Market Share by Region, 2023 & 2033 (%)
- 5.8 Obstructive Sleep Apnea
- 5.8.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 5.8.2 Market Share by Region, 2023 & 2033 (%)
- 5.9 Respiratory Distress Syndrome
- 5.9.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 5.9.2 Market Share by Region, 2023 & 2033 (%)
- 5.10 Other Applications
- 5.10.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 5.10.2 Market Share by Region, 2023 & 2033 (%)
- 6 Therapeutic Respiratory Devices Market Analysis by End-user
- 6.1 Key Findings
- 6.2 End-users Segment: Market Attractiveness Index
- 6.3 Therapeutic Respiratory Devices Market Size Estimation and Forecast by End-users
- 6.4 Homecare Settings
- 6.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 6.4.2 Market Share by Region, 2023 & 2033 (%)
- 6.5 Hospitals
- 6.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 6.5.2 Market Share by Region, 2023 & 2033 (%)
- 6.6 Others
- 6.6.1 Market Forecast by Region, 2023-2033 (US$ bn)
- 6.6.2 Market Share by Region, 2023 & 2033 (%)
- 7 Therapeutic Respiratory Devices Market Analysis by Distribution Channel
- 7.1 Key Findings
- 7.2 Distribution Channel Segment: Market Attractiveness Index
- 7.3 Therapeutic Respiratory Devices Market Size Estimation and Forecast by Distribution Channel
- 7.4 Retail Pharmacies
- 7.4.1 Retail Pharmacies Market Forecast by Region, 2023-2033 (US$ bn)
- 7.4.2 Retail Pharmacies Market Share by Region, 2023 & 2033 (%)
- 7.5 Hospital Pharmacies
- 7.5.1 Hospital Pharmacies Market Forecast by Region, 2023-2033 (US$ bn)
- 7.5.2 Hospital Pharmacies Market Share by Region, 2023 & 2033 (%)
- 7.6 Online Pharmacies
- 7.6.1 Online Pharmacy Market Forecast by Region, 2023-2033 (US$ bn)
- 7.6.2 Online Pharmacy Market Share by Region, 2023 & 2033 (%)
- 8 Therapeutic Respiratory Devices Market Analysis by Region
- 8.1 Key Findings
- 8.2 Regional Market Size Estimation and Forecast
- 9 North America Therapeutic Respiratory Devices Market Analysis
- 9.1 Key Findings
- 9.2 North America Therapeutic Respiratory Devices Market Attractiveness Index
- 9.3 North America Therapeutic Respiratory Devices Market by Country, 2023, 2028 & 2033 (US$ bn)
- 9.4 North America Therapeutic Respiratory Devices Market Size Estimation and Forecast by Country
- 9.5 North America Therapeutic Respiratory Devices Market Size Estimation and Forecast by Product
- 9.5.1 North America Inhalers Market Size Estimation and Forecast by Type
- 9.5.2 North America Ventilators Market Size Estimation and Forecast by Type
- 9.5.3 North America Humidifiers Market Size Estimation and Forecast by Type
- 9.5.4 North America Positive Airway Pressure (PAP) Devices Market Size Estimation and Forecast by Type
- 9.5.5 North America Oxygen Concentrators Market Size Estimation and Forecast by Type
- 9.5.6 North America Nebulizers Market Size Estimation and Forecast by Type
- 9.6 North America Therapeutic Respiratory Devices Market Size Estimation and Forecast by Application
- 9.7 North America Therapeutic Respiratory Devices Market Size Estimation and Forecast by End-users
- 9.8 North America Therapeutic Respiratory Devices Market Size Estimation and Forecast by Distribution Channel
- 9.9 U.S. Therapeutic Respiratory Devices Market Analysis
- 9.10 Canada Therapeutic Respiratory Devices Market Analysis
- 10 Europe Therapeutic Respiratory Devices Market Analysis
- 10.1 Key Findings
- 10.2 Europe Therapeutic Respiratory Devices Market Attractiveness Index
- 10.3 Europe Therapeutic Respiratory Devices Market by Country, 2023, 2028 & 2033 (US$ bn)
- 10.4 Europe Therapeutic Respiratory Devices Market Size Estimation and Forecast by Country
- 10.5 Europe Therapeutic Respiratory Devices Market Size Estimation and Forecast by Product
- 10.5.1 Europe Inhalers Market Size Estimation and Forecast by Type
- 10.5.2 Europe Ventilators Market Size Estimation and Forecast by Type
- 10.5.3 Europe Humidifiers Market Size Estimation and Forecast by Type
- 10.5.4 Europe Positive Airway Pressure (PAP) Devices Market Size Estimation and Forecast by Type
- 10.5.5 Europe Oxygen Concentrators Market Size Estimation and Forecast by Type
- 10.5.6 Europe Nebulizers Market Size Estimation and Forecast by Type
- 10.6 Europe Therapeutic Respiratory Devices Market Size Estimation and Forecast by Application
- 10.7 Europe Therapeutic Respiratory Devices Market Size Estimation and Forecast by End-users
- 10.8 Europe Therapeutic Respiratory Devices Market Size Estimation and Forecast by Distribution Channel
- 10.9 Germany Therapeutic Respiratory Devices Market Analysis
- 10.10 UK Therapeutic Respiratory Devices Market Analysis
- 10.11 France Therapeutic Respiratory Devices Market Analysis
- 10.12 Italy Therapeutic Respiratory Devices Market Analysis
- 10.13 Spain Therapeutic Respiratory Devices Market Analysis
- 10.14 Russia Therapeutic Respiratory Devices Market Analysis
- 10.15 Rest of Europe Therapeutic Respiratory Devices Market Analysis
- 11 Asia Pacific Therapeutic Respiratory Devices Market Analysis
- 11.1 Key Findings
- 11.2 Asia Pacific Therapeutic Respiratory Devices Market Attractiveness Index
- 11.3 Asia Pacific Therapeutic Respiratory Devices Market by Country, 2023, 2028 & 2033 (US$ bn)
- 11.4 Asia Pacific Therapeutic Respiratory Devices Market Size Estimation and Forecast by Country
- 11.5 Asia Pacific Therapeutic Respiratory Devices Market Size Estimation and Forecast by Product
- 11.5.1 Asia Pacific Inhalers Market Size Estimation and Forecast by Type
- 11.5.2 Asia Pacific Ventilators Market Size Estimation and Forecast by Type
- 11.5.3 Asia Pacific Humidifiers Market Size Estimation and Forecast by Type
- 11.5.4 Asia Pacific Positive Airway Pressure (PAP) Devices Market Size Estimation and Forecast by Type
- 11.5.5 Asia Pacific Oxygen Concentrators Market Size Estimation and Forecast by Type
- 11.5.6 Asia Pacific Nebulizers Market Size Estimation and Forecast by Type
- 11.6 Asia Pacific Therapeutic Respiratory Devices Market Size Estimation and Forecast by Application
- 11.7 Asia Pacific Therapeutic Respiratory Devices Market Size Estimation and Forecast by End-users
- 11.8 Asia Pacific Therapeutic Respiratory Devices Market Size Estimation and Forecast by Distribution Channel
- 11.9 Japan Therapeutic Respiratory Devices Market Analysis
- 11.10 China Therapeutic Respiratory Devices Market Analysis
- 11.11 India Therapeutic Respiratory Devices Market Analysis
- 11.12 Australia Therapeutic Respiratory Devices Market Analysis
- 11.13 South Korea Therapeutic Respiratory Devices Market Analysis
- 11.14 Rest of Asia Pacific Therapeutic Respiratory Devices Market Analysis
- 12 Latin America Therapeutic Respiratory Devices Market Analysis
- 12.1 Key Findings
- 12.2 Latin America Therapeutic Respiratory Devices Market Attractiveness Index
- 12.3 Latin America Therapeutic Respiratory Devices Market by Country, 2023, 2028 & 2033 (US$ bn)
- 12.4 Latin America Therapeutic Respiratory Devices Market Size Estimation and Forecast by Country
- 12.5 Latin America Therapeutic Respiratory Devices Market Size Estimation and Forecast by Product
- 12.5.1 Latin America Inhalers Market Size Estimation and Forecast by Type
- 12.5.2 Latin America Ventilators Market Size Estimation and Forecast by Type
- 12.5.3 Latin America Humidifiers Market Size Estimation and Forecast by Type
- 12.5.4 Latin America Positive Airway Pressure (PAP) Devices Market Size Estimation and Forecast by Type
- 12.5.5 Latin America Oxygen Concentrators Market Size Estimation and Forecast by Type
- 12.5.6 Latin America Nebulizers Market Size Estimation and Forecast by Type
- 12.6 Latin America Therapeutic Respiratory Devices Market Size Estimation and Forecast by Application
- 12.7 Latin America Therapeutic Respiratory Devices Market Size Estimation and Forecast by End-users
- 12.8 Latin America Therapeutic Respiratory Devices Market Size Estimation and Forecast by Distribution Channel
- 12.9 Brazil Therapeutic Respiratory Devices Market Analysis
- 12.10 Mexico Therapeutic Respiratory Devices Market Analysis
- 12.11 Argentina Therapeutic Respiratory Devices Market Analysis
- 12.12 Rest of Latin America Therapeutic Respiratory Devices Market Analysis
- 13 MEA Therapeutic Respiratory Devices Market Analysis
- 13.1 Key Findings
- 13.2 MEA Therapeutic Respiratory Devices Market Attractiveness Index
- 13.3 MEA Therapeutic Respiratory Devices Market by Country, 2023, 2028 & 2033 (US$ bn)
- 13.4 MEA Therapeutic Respiratory Devices Market Size Estimation and Forecast by Country
- 13.5 MEA Therapeutic Respiratory Devices Market Size Estimation and Forecast by Product
- 13.5.1 MEA Inhalers Market Size Estimation and Forecast by Type
- 13.5.2 MEA Ventilators Market Size Estimation and Forecast by Type
- 13.5.3 MEA Humidifiers Market Size Estimation and Forecast by Type
- 13.5.4 MEA Positive Airway Pressure (PAP) Devices Market Size Estimation and Forecast by Type
- 13.5.5 MEA Oxygen Concentrators Market Size Estimation and Forecast by Type
- 13.5.6 MEA Nebulizers Market Size Estimation and Forecast by Type
- 13.6 MEA Therapeutic Respiratory Devices Market Size Estimation and Forecast by Application
- 13.7 MEA Therapeutic Respiratory Devices Market Size Estimation and Forecast by End-users
- 13.8 MEA Therapeutic Respiratory Devices Market Size Estimation and Forecast by Distribution Channel
- 13.9 GCC Therapeutic Respiratory Devices Market Analysis
- 13.10 South Africa Therapeutic Respiratory Devices Market Analysis
- 13.11 Rest of MEA Therapeutic Respiratory Devices Market Analysis
- 14 Company Profiles
- 14.1 Company Share Analysis
- 14.2 Strategic Outlook
- 14.3 GSK plc
- 14.3.1 Company Snapshot
- 14.3.2 Company Overview
- 14.3.3 Financial Analysis
- 14.3.3.1 Net Revenue, 2018-2022
- 14.3.3.2 Regional Revenue/Market Shares, 2022
- 14.3.3.3 Segmental Revenue/Market Shares, 2022
- 14.3.4 Product Benchmarking
- 14.3.5 Strategic Outlook
- 14.4 Koninklijke Philips N.V.
- 14.4.1 Company Snapshot
- 14.4.2 Company Overview
- 14.4.3 Financial Analysis
- 14.4.3.1 Net Revenue, 2018-2022
- 14.4.3.2 Regional Revenue/Market Shares, 2022
- 14.4.3.3 Segmental Revenue/Market Shares, 2022
- 14.4.4 Product Benchmarking
- 14.4.5 Strategic Outlook
- 14.5 Boehringer Ingelheim International GmbH
- 14.5.1 Company Snapshot
- 14.5.2 Company Overview
- 14.5.3 Financial Analysis
- 14.5.3.1 Net Revenue, 2017-2021
- 14.5.3.2 Regional Revenue/Market Shares, 2021
- 14.5.3.3 Segmental Revenue/Market Shares, 2022
- 14.5.4 Product Benchmarking
- 14.5.5 Strategic Outlook
- 14.6 GE Healthcare
- 14.6.1 Company Snapshot
- 14.6.2 Company Overview
- 14.6.3 Financial Analysis
- 14.6.3.1 Net Revenue, 2018-2022
- 14.6.3.2 Regional Revenue/Market Shares, 2022
- 14.6.3.3 Segmental Revenue/Market Shares, 2022
- 14.6.4 Product Benchmarking
- 14.6.5 Strategic Outlook
- 14.7 3M Health Care
- 14.7.1 Company Snapshot
- 14.7.2 Company Overview
- 14.7.3 Financial Analysis
- 14.7.3.1 Net Revenue, 2018-2022
- 14.7.3.2 Segmental Revenue/Market Shares, 2022
- 14.7.4 Product Benchmarking
- 14.8 AstraZeneca
- 14.8.1 Company Snapshot
- 14.8.2 Company Overview
- 14.8.3 Financial Analysis
- 14.8.3.1 Net Revenue, 2018-2022
- 14.8.3.2 Regional Revenue/Market Shares, 2022
- 14.8.3.3 Segmental Revenue/Market Shares, 2022
- 14.8.4 Product Benchmarking
- 14.8.5 Strategic Outlook
- 14.9 Merck & Co., Inc.
- 14.9.1 Company Snapshot
- 14.9.2 Company Overview
- 14.9.3 Financial Analysis
- 14.9.3.1 Net Revenue, 2018-2022
- 14.9.3.2 Regional Revenue/Market Shares, 2022
- 14.9.3.3 Segmental Revenue/Market Shares, 2022
- 14.9.4 Product Benchmarking
- 14.9.5 Strategic Outlook
- 14.10 Novartis AG
- 14.10.1 Company Snapshot
- 14.10.2 Company Overview
- 14.10.3 Financial Analysis
- 14.10.3.1 Net Revenue, 2018-2022
- 14.10.3.2 Regional Revenue/Market Shares, 2022
- 14.10.3.3 Segmental Revenue/Market Shares, 2022
- 14.10.4 Product Benchmarking
- 14.10.5 Strategic Outlook
- 14.11 OMRON Corporation
- 14.11.1 Company Snapshot
- 14.11.2 Company Overview
- 14.11.3 Financial Analysis
- 14.11.3.1 Net Revenue, 2018-2022
- 14.11.3.2 Regional Revenue/Market Shares, 2022
- 14.11.3.3 Segmental Revenue/Market Shares, 2022
- 14.11.4 Product Benchmarking
- 14.11.5 Strategic Outlook
- 14.12 Sunovion Pharmaceuticals Inc.
- 14.12.1 Company Snapshot
- 14.12.2 Company Overview
- 14.12.3 Financial Analysis
- 14.12.3.1 Net Revenue, 2017-2021
- 14.12.3.2 Regional Revenue/Market Shares, 2021
- 14.12.4 Product Benchmarking
- 14.12.5 Strategic Outlook
- 14.13 Teva Pharmaceutical Industries Ltd.
- 14.13.1 Company Snapshot
- 14.13.2 Company Overview
- 14.13.3 Financial Analysis
- 14.13.3.1 Net Revenue, 2018-2022
- 14.13.3.2 Regional Revenue/Market Shares, 2022
- 14.13.4 Product Benchmarking
- 14.13.5 Strategic Outlook
- 14.14 Cipla Inc.
- 14.14.1 Company Snapshot
- 14.14.2 Company Overview
- 14.14.3 Financial Analysis
- 14.14.3.1 Net Revenue, 2018-2022
- 14.14.4 Product Benchmarking
- 14.14.5 Strategic Outlook
- 14.15 Recipharm AB
- 14.15.1 Company Snapshot
- 14.15.2 Company Overview
- 14.15.3 Financial Analysis
- 14.15.3.1 Net Revenue, 2017-2021
- 14.15.3.2 Regional Revenue/Market Shares, 2021
- 14.15.3.3 Segmental Revenue/Market Shares, 2021
- 14.15.4 Product Benchmarking
- 14.15.5 Strategic Outlook
- 14.16 Medisana GmbH
- 14.16.1 Company Snapshot
- 14.16.2 Company Overview
- 14.16.3 Product Benchmarking
- 14.17 GF Health Products, Inc.
- 14.17.1 Company Snapshot
- 14.17.2 Company Overview
- 14.17.3 Product Benchmarking
- 14.18 AptarGroup, Inc.
- 14.18.1 Company Snapshot
- 14.18.2 Company Overview
- 14.18.3 Financial Analysis
- 14.18.3.1 Net Revenue, 2018-2022
- 14.18.3.2 Regional Revenue/Market Shares, 2022
- 14.18.3.3 Segmental Revenue/Market Shares, 2022
- 14.18.4 Product Benchmarking
- 14.18.5 Strategic Outlook
- 14.19 Airsep Corporation (Chart Industries)
- 14.19.1 Company Snapshot
- 14.19.2 Company Overview
- 14.19.3 Financial Analysis
- 14.19.3.1 Net Revenue, 2018-2022
- 14.19.3.2 Regional Market Shares, 2022
- 14.19.3.3 Segmental Market Shares, 2022
- 14.19.4 Product Benchmarking
- 14.20 Becton, Dickinson and Company (BD)
- 14.20.1 Company Snapshot
- 14.20.2 Company Overview
- 14.20.3 Product Benchmarking
- 14.20.4 Financial Analysis
- 14.20.4.1 Net Revenue, 2018-2022
- 14.20.4.2 Regional Market Shares, 2022
- 14.20.4.3 Segmental Market Shares, 2022
- 14.20.5 Strategic Outlook
- 14.21 Fisher & Paykel Healthcare Limited
- 14.21.1 Company Snapshot
- 14.21.2 Company Overview
- 14.21.3 Product Benchmarking
- 14.21.4 Strategic Outlook
- 14.22 Hamilton Medical
- 14.22.1 Company Snapshot
- 14.22.2 Company Overview
- 14.22.3 Product Benchmarking
- 14.23 Invacare
- 14.23.1 Company Snapshot
- 14.23.2 Company Overview
- 14.23.3 Financial Analysis
- 14.23.3.1 Net Revenue, 2018-2022
- 14.23.3.2 Regional Market Shares, 2022
- 14.23.3.3 Segmental Market Shares, 2022
- 14.23.4 Product Benchmarking
- 14.24 Medtronic
- 14.24.1 Company Snapshot
- 14.24.2 Company Overview
- 14.24.3 Financial Analysis
- 14.24.3.1 Net Revenue, 2019-2022
- 14.24.3.2 Regional Revenue/Market Shares, 2022
- 14.24.4 Product Benchmarking
- 14.24.5 Strategic Outlook
- 14.25 ResMed
- 14.25.1 Company Snapshot
- 14.25.2 Company Overview
- 14.25.3 Financial Analysis
- 14.25.3.1 Net Revenue, 2019-2022
- 14.25.3.2 Regional Revenue/Market Shares, 2022
- 14.25.4 Product Benchmarking
- 14.25.5 Strategic Outlook
- 14.26 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 14.26.1 Company Snapshot
- 14.26.2 Company Overview
- 14.26.3 Financial Analysis
- 14.26.3.1 Net Revenue, 2017-2021
- 14.26.3.2 Regional Revenue/Market Shares, 2022
- 14.26.4 Product Benchmarking
- 14.26.5 Strategic Outlook
- 14.27 Smiths Medical, Inc.
- 14.27.1 Company Snapshot
- 14.27.2 Company Overview
- 14.27.3 Financial Analysis
- 14.27.3.1 Net Revenue, 2017-2021
- 14.27.3.2 Regional Revenue/Market Shares, 2022
- 14.27.4 Product Benchmarking
- 14.27.5 Strategic Outlook
- 15 Conclusion and Recommendations
- 15.1 Concluding Remarks from
- 15.2 Recommendations for Market Players
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.